Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

Showing 20 of 0 results

Not applicableStudy completedNCT03712670
What this trial is testing

Nutraceutical Support With Omega-3

Who this might be right for
Retinal Disease
Università degli Studi di Brescia 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07607561
What this trial is testing

Phase 2a Study to Evaluate the Efficacy and Safety of SCAI-005 Ophthalmic Solution in Subjects With Neovascular Age-related Macular Degeneration

Who this might be right for
wetAMDAge Related Macular Degeneration
SCAI Therapeutics 50
Not applicableEnded earlyNCT02479386
What this trial is testing

Disease Progression in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Who this might be right for
Geographic Atrophy
Hoffmann-La Roche 296
Not applicableActive Not RecruitingNCT05439759
What this trial is testing

Factors in Learning And Plasticity: Healthy Vision

Who this might be right for
Central Visual ImpairmentMacular Degeneration
University of Alabama at Birmingham 120
Not applicableEnded earlyNCT01213888
What this trial is testing

Trientine Hydrochloride for the Prevention of Macular Edema Associated With Pan-retinal Photocoagulation for Severe Non-proliferative and Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
University of British Columbia 3
Not applicableUnknownNCT05283941
What this trial is testing

Pistachios and Neural Macular Pigment

Who this might be right for
Macular DegenerationRetinal DegenerationRetinal Diseases+1 more
Tufts University 40
Large-scale testing (Phase 3)Study completedNCT00331864
What this trial is testing

SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

Who this might be right for
Age Related Macular DegenerationChoroidal Neovascularization
Novartis 531
Large-scale testing (Phase 3)Looking for participantsNCT07317934
What this trial is testing

Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (STELLAR)

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)Wet AMD
Innostellar Biotherapeutics Co.,Ltd 388
Testing effectiveness (Phase 2)Ended earlyNCT00692614
What this trial is testing

MK0140 in Diabetic Patients With Macular Edema (0140-001)

Who this might be right for
Macular Edema
Merck Sharp & Dohme LLC 2
Early research (Phase 1)Study completedNCT03835884
What this trial is testing

A Study Assessing AR-13503 Implant in Subjects With nAMD or DME

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Aerie Pharmaceuticals 18
Testing effectiveness (Phase 2)Study completedNCT01796964
What this trial is testing

Efficacy and Safety Study of ESBA1008 Versus EYLEA®

Who this might be right for
Exudative Age-Related Macular Degeneration
Alcon Research 173
Testing effectiveness (Phase 2)Study completedNCT05403749
What this trial is testing

Longer Interval of IVT IBI302 in Subjects With nAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Innovent Biologics (Suzhou) Co. Ltd. 132
Early research (Phase 1)Study completedNCT06213038
What this trial is testing

A Clinical Study Evaluating the Safety and Efficacy of SKG0106 in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Youxin Chen 12
Not applicableWithdrawnNCT04045704
What this trial is testing

Cataract Surgery on Advanced Age Related Macular Degeneration Patients

Who this might be right for
CataractMacular Degeneration Advanced
University of British Columbia
Not applicableStudy completedNCT03939767
What this trial is testing

Assessment of Proactive Treatments in Patients With Wet Age-related Macular Degeneration (wAMD) Which Have Never Undergone Treatment of This Particular Disease

Who this might be right for
Wet Age-related Macular Degeneration
Bayer 1,563
Large-scale testing (Phase 3)Study completedNCT00056836
What this trial is testing

Evaluate rhuFab V2 in Subjects With Minimally Classic or Occult Subfoveal Neovascular Macular Degeneration

Who this might be right for
Macular Degeneration
Genentech, Inc. 720
Not applicableStudy completedNCT02558712
What this trial is testing

Technology-based Eye Care Services (TECS) Compare

Who this might be right for
CataractMacular DegenerationGlaucoma
Emory University 256
Testing effectiveness (Phase 2)UnknownNCT00809419
What this trial is testing

The NeoVista Ophthalmic System for the Treatment of Subfoveal CNV Associated With Wet AMD in Patients That Require Persistent Anti-VEGF Therapy

Who this might be right for
Age Related Macular Degeneration
NeoVista 32
Not applicableStudy completedNCT00555165
What this trial is testing

An Implantable Miniature Telescope in Patients With With End-Stage AMD

Who this might be right for
End Stage Macular Degeneration
VisionCare, Inc. 18
Early research (Phase 1)Study completedNCT05953012
What this trial is testing

Study to Assess Safety and Tolerability of PMC-403 in Subjects With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
PharmAbcine 17
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation